Pathogenesis of Bronchiectasis

Clinics in Chest Medicine

Volumn 33, Issue 2, 2012, Pages 211-217

  Moulton, Bart C ^a   Barker, Alan F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Airway epithelium; Bronchiectasis; Pathogenesis; Sputum

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIUM; BRONCHIECTASIS; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; HAEMOPHILUS INFLUENZAE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOST PATHOGEN INTERACTION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LUNG BIOPSY; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MOLECULAR PATHOLOGY; MUCOCILIARY TRANSPORT; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; REVIEW; SYNDROME DELINEATION;

BRONCHIECTASIS; HUMANS; INFECTION; INFLAMMATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861545386     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2012.02.004     Document Type: Review

References (49)

1. Laennec R.T. A treatise on the disease[s] of the chest 1962, Published under the auspices of the Library of the New York Academy of Medicine by Hafner Pub. Co, New York.
2. Reid L.M. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950, 5(3):233-247.
3. Barker A.F. Bronchiectasis. N Engl J Med 2002, 346(18):1383-1393.
4. Weycker D., Edelsberg J., Oster G., et al. Prevalence and economic burden of bronchiectasis. Clin Pulm Med 2005, 12(4):205-209.
5. Chang A.B., Grimwood K., Mulholland E.K., et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002, 177(4):200-204.
6. Singleton R., Morris A., Redding G., et al. Bronchiectasis in Alaska native children: causes and clinical courses. Pediatr Pulmonol 2000, 29(3):182-187.
7. Allbutt T.C., Rolleston H.D. A system of medicine 1905, Macmillan & Co, New York, London.
8. Tasker A.D., Flower C.D. Imaging the airways. Hemoptysis, bronchiectasis, and small airways disease. Clin Chest Med 1999, 20(4):761-773. viii.
9. Kang E.Y., Miller R.R., Muller N.L. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 1995, 195(3):649-654.
10. Redding G.J., Kishioka C., Martinez P., et al. Physical and transport properties of sputum from children with idiopathic bronchiectasis. Chest 2008, 134(6):1129-1134.
11. van de Ven A.A., van Montfrans J.M., Terheggen-Lagro S.W., et al. A CT scan score for the assessment of lung disease in children with common variable immunodeficiency disorders. Chest 2010, 138(2):371-379.
12. Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax 1952, 7(3):213-239.
13. Cole P.J. Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl 1986, 147:6-15.
14. Travis S.M., Singh P.K., Welsh M.J. Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr Opin Immunol 2001, 13(1):89-95.
15. Lukinskiene L., Liu Y., Reynolds S.D., et al. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol 2011, 187(1):382-390.
16. Roche W.R., Montefort S., Baker J., et al. Cell adhesion molecules and the bronchial epithelium. Am Rev Respir Dis 1993, 148(6 Pt 2):S79-S82.
17. Willoughby R.A., Ecker G.L., McKee S.L., et al. Use of scintigraphy for the determination of mucociliary clearance rates in normal, sedated, diseased and exercised horses. Can J Vet Res 1991, 55(4):315-320.
18. Goeminne P.C., Dupont L.J. The sinusitis-infertility syndrome: Young's saint, old devil. Eur Respir J 2010, 35(3):698.
19. Boyton R.J. Regulation of immunity in bronchiectasis. Med Mycol 2009, 47(Suppl 1):S175-S182.
20. Tegner H., Ohlsson K., Toremalm N.G., et al. Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology 1979, 17(3):199-206.
21. Smallman L.A., Hill S.L., Stockley R.A. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax 1984, 39(9):663-667.
22. Bienvenu T., Sermet-Gaudelus I., Burgel P.R., et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010, 181(10):1078-1084.
23. Frick A.G., Joseph T.D., Pang L., et al. Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells. J Immunol 2000, 164(8):4185-4196.
24. Yang L., Froio R.M., Sciuto T.E., et al. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 2005, 106(2):584-592.
25. Wilson C.B., Jones P.W., O'Leary C.J., et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998, 12(4):820-824.
26. Zheng L., Shum H., Tipoe G.L., et al. Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo. Respir Med 2001, 95(10):792-798.
27. Gaga M., Bentley A.M., Humbert M., et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998, 53(8):685-691.
28. Loukides S., Bouros D., Papatheodorou G., et al. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002, 121(1):81-87.
29. Eller J., Lapa e Silva J.R., Poulter L.W., et al. Cells and cytokines in chronic bronchial infection. Ann N Y Acad Sci 1994, 725:331-345.
30. Roussel L., Houle F., Chan C., et al. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 2010, 184(8):4531-4537.
31. Salva P.S., Doyle N.A., Graham L., et al. TNF-alpha, IL-8, soluble ICAM-1, and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonol 1996, 21(1):11-19.
32. Beeh K.M., Kornmann O., Buhl R., et al. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 2003, 123(4):1240-1247.
33. Stockley R.A. Neutrophils and protease/antiprotease imbalance. Am J Respir Crit Care Med 1999, 160(5 Pt 2):S49-S52.
34. Voglis S., Quinn K., Tullis E., et al. Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs. Am J Respir Crit Care Med 2009, 180(2):159-166.
35. Gadola S.D., Moins-Teisserenc H.T., Trowsdale J., et al. TAP deficiency syndrome. Clin Exp Immunol 2000, 121(2):173-178.
36. Stockley R.A. The role of proteinases in the pathogenesis of chronic bronchitis. Am J Respir Crit Care Med 1994, 150(6 Pt 2):S109-S113.
37. Sepper R., Konttinen Y.T., Ingman T., et al. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis. J Clin Immunol 1995, 15(1):27-34.
38. Silva J.R., Jones J.A., Cole P.J., et al. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989, 44(8):668-673.
39. Bjorkman P.J., Saper M.A., Samraoui B., et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329(6139):512-518.
40. Boyton R.J., Smith J., Ward R., et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2006, 173(3):327-333.
41. Wickremasinghe M., Ozerovitch L.J., Davies G., et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005, 60(12):1045-1051.
42. Tatano Y., Yasumoto K., Shimizu T., et al. Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases. Eur J Clin Microbiol Infect Dis 2010, 29(7):801-806.
43. Rosen F.S., Cooper M.D., Wedgwood R.J. The primary immunodeficiencies. N Engl J Med 1995, 333(7):431-440.
44. Hartl D., Latzin P., Hordijk P., et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007, 13(12):1423-1430.
45. Llewellyn-Jones C.G., Lomas D.A., Stockley R.A. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax 1994, 49(6):567-572.
46. Parr D.G., Guest P.G., Reynolds J.H., et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2007, 176(12):1215-1221.
47. Cuvelier A., Muir J.F., Hellot M.F., et al. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest 2000, 117(2):415-419.
48. Sadikot R.T., Blackwell T.S., Christman J.W., et al. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005, 171(11):1209-1223.
49. Zuyderduyn S., Ninaber D.K., Schrumpf J.A., et al. IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides. Respir Res 2011, 12:59.